RVTY
Revvity, Inc. NYSE Listed Jul 6, 1965$100.00
+2.23%
vs $97.82
Mkt Cap $11.2B
52w Low $81.22
50.6% of range
52w High $118.30
50d MA $95.49
200d MA $95.53
P/E (TTM)
48.1x
EV/EBITDA
19.9x
P/B
1.6x
Debt/Equity
0.5x
ROE
3.3%
P/FCF
22.3x
RSI (14)
41.90
ATR (14)
$3.69
Beta
1.13
50d MA
$95.49
200d MA
$95.53
Avg Volume
1.5M
Revvity, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection, and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023. Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.
77 4th Avenue · Waltham, MA 02451 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 5, 2026 | TNS | 1.02 | 1.06 | +3.9% | 92.30 | +1.3% | +7.4% | -0.2% | +2.2% | -2.0% | +0.4% | — |
| Feb 2, 2026 | TNS | 1.57 | 1.70 | +8.3% | 107.09 | +1.7% | -5.6% | +0.0% | +2.7% | -4.2% | +2.1% | — |
| Oct 27, 2025 | TNS | 1.14 | 1.18 | +3.5% | 97.16 | +1.2% | -0.7% | +0.0% | -1.2% | -4.5% | +2.8% | — |
| Jul 28, 2025 | TNS | 1.14 | 1.18 | +3.5% | 95.04 | -0.2% | -0.6% | +0.0% | -3.8% | -3.2% | +0.4% | — |
| Apr 28, 2025 | TNS | 0.96 | 1.01 | +5.2% | 95.06 | -0.1% | -0.4% | +0.0% | -1.3% | -0.6% | +1.2% | — |
| Jan 31, 2025 | TNS | 1.37 | 1.42 | +3.6% | 126.13 | -0.3% | -1.9% | +0.0% | -0.4% | -0.6% | -2.6% | — |
| Nov 4, 2024 | TNS | 1.13 | 1.28 | +13.3% | 124.82 | -1.2% | +0.9% | +0.0% | -0.9% | -0.7% | -1.2% | — |
| Jul 29, 2024 | TNS | 1.12 | 1.22 | +8.9% | 125.59 | +0.3% | +1.3% | +0.0% | -1.2% | -0.5% | -1.4% | — |
| Apr 29, 2024 | TNS | 0.94 | 0.98 | +3.9% | 105.02 | -0.7% | -2.4% | +0.0% | +0.1% | -1.5% | -0.5% | — |
| Feb 1, 2024 | TNS | 1.15 | 1.25 | +8.7% | 109.26 | -0.4% | -3.3% | +0.0% | -1.6% | +0.3% | -1.3% | — |
| Oct 30, 2023 | TNS | 1.19 | 1.18 | -0.8% | 82.08 | +0.5% | +0.9% | +0.0% | -0.4% | +1.7% | +5.0% | — |
| Aug 1, 2023 | TNS | 1.18 | 1.21 | +2.5% | 122.63 | -1.4% | +2.0% | +0.0% | -1.6% | +0.1% | -0.4% | — |
| May 11, 2023 | BMO | 1.06 | 1.01 | -4.7% | 118.37 | -0.8% | -1.7% | +0.0% | -0.9% | -0.9% | +0.9% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 2 | Wolfe Research | Reiterates | Peer Perform | — | $100.52 | $98.44 | -2.1% | -0.1% | +0.7% | +1.3% | -3.9% | +2.0% |
| Apr 14 | Barclays | Downgrade | Overweight → Equal Weight | — | $92.64 | $92.50 | -0.2% | +0.9% | -0.7% | -3.6% | +4.9% | -1.0% |
| Apr 14 | Goldman Sachs | Maintains | Neutral → Neutral | — | $92.64 | $92.50 | -0.2% | +0.9% | -0.7% | -3.6% | +4.9% | -1.0% |
| Mar 31 | JP Morgan | Maintains | Neutral → Neutral | — | $84.78 | $86.20 | +1.7% | +3.3% | +0.4% | +1.2% | -0.7% | -0.6% |
| Feb 3 | JP Morgan | Maintains | Neutral → Neutral | — | $107.09 | $108.91 | +1.7% | -5.6% | +2.7% | -4.2% | +2.1% | +1.2% |
| Feb 3 | Jefferies | Maintains | Hold → Hold | — | $107.09 | $108.91 | +1.7% | -5.6% | +2.7% | -4.2% | +2.1% | +1.2% |
| Feb 3 | Evercore ISI | Maintains | Outperform → Outperform | — | $107.09 | $108.91 | +1.7% | -5.6% | +2.7% | -4.2% | +2.1% | +1.2% |
| Feb 3 | Barclays | Maintains | Overweight → Overweight | — | $107.09 | $108.91 | +1.7% | -5.6% | +2.7% | -4.2% | +2.1% | +1.2% |
| Feb 3 | TD Cowen | Maintains | Buy → Buy | — | $107.09 | $108.91 | +1.7% | -5.6% | +2.7% | -4.2% | +2.1% | +1.2% |
| Feb 3 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $107.09 | $108.91 | +1.7% | -5.6% | +2.7% | -4.2% | +2.1% | +1.2% |
| Dec 15 | Barclays | Maintains | Overweight → Overweight | — | $100.49 | $100.03 | -0.5% | -1.4% | -2.8% | +0.5% | -0.5% | -0.0% |
| Dec 15 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $100.49 | $100.03 | -0.5% | -1.4% | -2.8% | +0.5% | -0.5% | -0.0% |
| Oct 28 | Barclays | Maintains | Overweight → Overweight | — | $97.16 | $98.33 | +1.2% | -0.7% | -1.2% | -4.5% | +2.8% | -0.7% |
| Oct 28 | Baird | Maintains | Outperform → Outperform | — | $97.16 | $98.33 | +1.2% | -0.7% | -1.2% | -4.5% | +2.8% | -0.7% |
| Oct 7 | Evercore ISI | Maintains | Outperform → Outperform | — | $93.38 | $93.80 | +0.4% | -2.3% | +0.6% | -0.1% | -3.7% | +3.0% |
| Oct 2 | Barclays | Maintains | Overweight → Overweight | — | $91.76 | $90.54 | -1.3% | -0.3% | +2.8% | -0.7% | -2.3% | +0.6% |
| Sep 22 | BofA Securities | Maintains | Buy → Buy | — | $86.72 | $85.93 | -0.9% | -0.5% | -0.6% | -1.4% | -1.7% | +1.2% |
| Jul 29 | Raymond James | Maintains | Outperform → Outperform | — | $95.04 | $94.84 | -0.2% | -0.6% | -3.8% | -3.2% | +0.4% | +0.1% |
| Jul 29 | Stifel | Maintains | Hold → Hold | — | $95.04 | $94.84 | -0.2% | -0.6% | -3.8% | -3.2% | +0.4% | +0.1% |
| Jul 8 | Evercore ISI | Maintains | Outperform → Outperform | — | $98.71 | $98.83 | +0.1% | +2.0% | -0.5% | +2.3% | -0.9% | -3.0% |
| Jun 26 | BofA Securities | Maintains | Buy → Buy | — | $97.70 | $98.18 | +0.5% | +1.1% | -1.0% | -1.1% | +2.4% | +1.9% |
| May 1 | UBS | Upgrade | Neutral → Buy | — | $93.43 | $94.89 | +1.6% | -0.6% | +1.2% | -1.2% | -2.6% | +1.3% |
| Apr 29 | Goldman Sachs | Maintains | Buy → Buy | — | $95.06 | $94.92 | -0.1% | -0.4% | -1.3% | -0.6% | +1.2% | -1.2% |
| Apr 29 | Raymond James | Maintains | Outperform → Outperform | — | $95.06 | $94.92 | -0.1% | -0.4% | -1.3% | -0.6% | +1.2% | -1.2% |
| Apr 29 | JP Morgan | Maintains | Neutral → Neutral | — | $95.06 | $94.92 | -0.1% | -0.4% | -1.3% | -0.6% | +1.2% | -1.2% |
| Apr 29 | Baird | Maintains | Outperform → Outperform | — | $95.06 | $94.92 | -0.1% | -0.4% | -1.3% | -0.6% | +1.2% | -1.2% |
| Apr 21 | Baird | Maintains | Outperform → Outperform | — | $91.82 | $90.88 | -1.0% | -2.2% | +2.9% | +1.5% | +1.5% | -0.9% |
| Apr 17 | Wells Fargo | Maintains | Equal Weight → Equal Weight | — | $93.75 | $93.25 | -0.5% | -2.1% | -2.2% | +2.9% | +1.5% | +1.5% |
| Apr 10 | Barclays | Maintains | Overweight → Overweight | — | $101.34 | $99.00 | -2.3% | -8.2% | +2.0% | +2.9% | -2.1% | -1.9% |
| Feb 3 | KeyBanc Capital Markets | Maintains | Overweight → Overweight | — | $126.13 | $125.74 | -0.3% | -1.9% | -0.4% | -0.6% | -2.6% | -0.3% |
| Feb 3 | Raymond James | Maintains | Outperform → Outperform | — | $126.13 | $125.74 | -0.3% | -1.9% | -0.4% | -0.6% | -2.6% | -0.3% |
| Feb 3 | Barclays | Maintains | Overweight → Overweight | — | $126.13 | $125.74 | -0.3% | -1.9% | -0.4% | -0.6% | -2.6% | -0.3% |
| Jan 21 | Raymond James | Maintains | Outperform → Outperform | — | $118.39 | $119.02 | +0.5% | +4.7% | -0.9% | +0.2% | +0.1% | +0.7% |
| Dec 13 | BofA Securities | Upgrade | Neutral → Buy | — | $116.01 | $116.71 | +0.6% | -0.1% | -0.7% | -0.4% | -4.9% | +1.3% |
| Nov 25 | Barclays | Maintains | Overweight → Overweight | — | $112.03 | $113.00 | +0.9% | +2.3% | +0.4% | +1.0% | -0.1% | +0.5% |
| Nov 5 | Baird | Maintains | Outperform → Outperform | — | $124.82 | $123.29 | -1.2% | +0.9% | -0.9% | -0.7% | -1.2% | -1.5% |
| Nov 5 | TD Cowen | Maintains | Buy → Buy | — | $124.82 | $123.29 | -1.2% | +0.9% | -0.9% | -0.7% | -1.2% | -1.5% |
| Nov 5 | Bernstein | Maintains | Outperform → Outperform | — | $124.82 | $123.29 | -1.2% | +0.9% | -0.9% | -0.7% | -1.2% | -1.5% |
| Nov 5 | Raymond James | Maintains | Outperform → Outperform | — | $124.82 | $123.29 | -1.2% | +0.9% | -0.9% | -0.7% | -1.2% | -1.5% |
| Oct 17 | Leerink Partners | Maintains | Outperform → Outperform | — | $120.18 | $121.70 | +1.3% | -0.9% | +0.5% | -0.4% | -0.4% | -0.2% |
| Oct 15 | Barclays | Upgrade | Equal Weight → Overweight | — | $122.91 | $124.61 | +1.4% | +1.2% | -3.4% | -0.9% | +0.5% | -0.4% |
| Jul 30 | TD Cowen | Maintains | Buy → Buy | — | $125.59 | $126.02 | +0.3% | +1.3% | -1.2% | -0.5% | -1.4% | -2.5% |
| Jul 30 | Citigroup | Maintains | Buy → Buy | — | $125.59 | $126.02 | +0.3% | +1.3% | -1.2% | -0.5% | -1.4% | -2.5% |
| Jul 30 | Barclays | Maintains | Equal Weight → Equal Weight | — | $125.59 | $126.02 | +0.3% | +1.3% | -1.2% | -0.5% | -1.4% | -2.5% |
| Jul 30 | BofA Securities | Maintains | Neutral → Neutral | — | $125.59 | $126.02 | +0.3% | +1.3% | -1.2% | -0.5% | -1.4% | -2.5% |
| Jul 30 | JP Morgan | Maintains | Neutral → Neutral | — | $125.59 | $126.02 | +0.3% | +1.3% | -1.2% | -0.5% | -1.4% | -2.5% |
| Jul 29 | Jefferies | Maintains | Hold → Hold | — | $115.15 | $121.44 | +5.5% | +9.1% | +1.3% | -1.2% | -0.5% | -1.4% |
| Jun 28 | Barclays | Maintains | Equal Weight → Equal Weight | — | $105.71 | $105.62 | -0.1% | -0.8% | -1.8% | -1.0% | +0.5% | +1.0% |
| Apr 30 | Baird | Maintains | Outperform → Outperform | — | $105.02 | $104.30 | -0.7% | -2.4% | +0.1% | -1.5% | -0.5% | +2.2% |
| Apr 30 | TD Cowen | Maintains | Buy → Buy | — | $105.02 | $104.30 | -0.7% | -2.4% | +0.1% | -1.5% | -0.5% | +2.2% |
No insider trades available.
8-K · 2.02
!! High
Revvity, Inc. -- 8-K 2.02: Earnings Results
Revvity reported Q1 2026 earnings on May 5, 2026, with results ending April 5, 2026, providing investors updated financial performance metrics for the quarter.
May 5
8-K
Revvity, Inc. -- 8-K Filing
Revvity reported Q4 2025 revenue of $772 million with 6% growth and adjusted EPS of $1.70, while initiating 2026 guidance to support investor forward planning.
Feb 2
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Edgepoint Investment Group Inc. | 8,535,659 | $826M | — | Dec 2025 |
| 2 | Janus Henderson Group Plc | 8,348,127 | $731M | New | Mar 2026 |
| 3 | Vanguard Capital Management Llc | 7,329,980 | $642M | New | Mar 2026 |
| 4 | Morgan Stanley | 5,688,928 | $550M | Added | Dec 2025 |
| 5 | Vanguard Portfolio Management Llc | 4,813,167 | $422M | New | Mar 2026 |
| 6 | Victory Capital Management Inc | 3,372,627 | $295M | Added | Mar 2026 |
| 7 | Invesco Ltd. | 2,718,064 | $238M | Added | Mar 2026 |
| 8 | Allspring Global Investments Holdings, Llc | 2,259,286 | $199M | Added | Mar 2026 |
| 9 | Pictet Asset Management Holding Sa | 1,363,782 | $132M | Reduced | Dec 2025 |
| 10 | Neuberger Berman Group Llc | 1,387,379 | $122M | Added | Mar 2026 |
| 11 | Ubs Group Ag | 1,355,576 | $119M | Reduced | Mar 2026 |
| 12 | Northern Trust Corp | 928,524 | $81M | Reduced | Mar 2026 |
| 13 | Bank Of America Corp /de/ | 880,503 | $77M | Added | Mar 2026 |
| 14 | Primecap Management Co/ca/ | 867,030 | $76M | Reduced | Mar 2026 |
| 15 | Jane Street Group, Llc | 654,056 | $63M | New | Dec 2025 |
| 16 | Sei Investments Co | 703,406 | $62M | Added | Mar 2026 |
| 17 | Bank Of New York Mellon Corp | 637,406 | $56M | Reduced | Mar 2026 |
| 18 | Diamond Hill Capital Management Inc | 426,899 | $41M | Added | Dec 2025 |
| 19 | Jpmorgan Chase & Co | 396,639 | $34M | Added | Mar 2026 |
| 20 | Fmr Llc | 349,390 | $31M | Added | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$11.16B
Enterprise Value
$13.18B
P/E (TTM)
48.08x
Forward P/E
18.54x
PEG Ratio
-3.32x
P/B
1.56x
P/S
3.96x
P/FCF
22.27x
EV/EBITDA
19.89x
Shares Out
113.2M
Financials (TTM)
Revenue
$2.86B
Net Income
$241.7M
EBITDA
$662.7M
Free Cash Flow
$508.3M
Op Cash Flow
$581.8M
EPS Basic
$2.08
EPS Diluted
$2.08
EPS Forward
$5.39
Gross Margin
53.1%
Op Margin
12.5%
Net Margin
8.5%
Balance Sheet
Total Assets
$12.17B
Total Liab.
$4.92B
Total Equity
$7.25B
Cash
$919.9M
LT Debt
$2.78B
Book Value/Sh
$64.04
Debt/Equity
0.48x
Current Ratio
1.68
Quick Ratio
1.40
Returns & Growth
ROE
3.3%
ROA
2.0%
ROIC
2.8%
Rev Growth YoY
+3.7%
EPS Growth YoY
-13.7%
Price Returns
2W
+8.5%
1M
+20.7%
3M
+6.3%
6M
+0.1%
12M
+15.6%
Technicals
52W High
$118.30
52W Low
$81.22
50d MA
$95.49
200d MA
$95.53
RSI (14)
41.90
ATR (14)
$3.69
Beta
1.13
Avg Volume
1.5M
Dividends
Div Rate
$0.29
Div Yield
0.3%
Frequency
4
Ex-Div Date
Apr 17, 2026
Analyst Price Targets
Consensus
$111.86
High
$129.00
Low
$95.00
Median
$107.00
Data updated apr 26, 2026 11:45pm
· Source: financialmodelingprep.com